{"filing":{"accession_number":"0001193125-26-297658","cik":"0000943819","ticker":"RSMDF","company_name":"RESMED INC","form":"8-K","filing_date":"2026-07-07","report_date":null,"primary_document":"d88958d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/943819/000119312526297658/d88958d8k.htm"},"events":[{"id":16530,"run_id":14769,"accession_number":"0001193125-26-297658","anchor_item_number":"2.02","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"summary":"ResMed entered into a definitive agreement to sell its MatrixCare business to Frazier Healthcare Partners for $490 million in an all-cash transaction expected to close in Q1 fiscal 2027. The disposition represents approximately $220 million in annual revenue and $55 million in non-GAAP operating profit, reflecting a strategic portfolio shift toward high-growth sleep and connected care markets. The company plans to return net proceeds to shareholders via an accelerated share repurchase program.","company_name":"RESMED INC","ticker":"RSMDF","filing_date":"2026-07-07","form":"8-K","submitted_at":null,"items":[{"id":14663,"accession_number":"0001193125-26-297658","item_number":"2.02","item_title":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"ResMed entered into a definitive agreement to sell its MatrixCare business to Frazier Healthcare Partners for $490 million in an all-cash transaction expected to close in Q1 fiscal 2027. This is a material disposition of a business segment representing approximately $220 million in annual revenue and $55 million in non-GAAP operating profit. The company plans to return net proceeds to shareholders via an accelerated share repurchase program, making this a significant capital allocation event.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-07T21:25:40.020532+00:00","company_name":"","ticker":null,"filing_date":""},{"id":14664,"accession_number":"0001193125-26-297658","item_number":"7.01","item_title":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"Resmed announced entry into a definitive agreement to sell its MatrixCare business to Frazier Healthcare Partners. This is a material disposition of a business segment that serves over 15,000 providers in skilled nursing, senior living, and long-term care markets. The transaction is expected to close in Q1 FY2027 and reflects a strategic portfolio shift toward high-growth sleep and connected care markets, making it a material M\u0026A event requiring 8-K disclosure under Item 1.01 or 2.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-07T21:25:40.020532+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":14663,"accession_number":"0001193125-26-297658","item_number":"2.02","item_title":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"ResMed entered into a definitive agreement to sell its MatrixCare business to Frazier Healthcare Partners for $490 million in an all-cash transaction expected to close in Q1 fiscal 2027. This is a material disposition of a business segment representing approximately $220 million in annual revenue and $55 million in non-GAAP operating profit. The company plans to return net proceeds to shareholders via an accelerated share repurchase program, making this a significant capital allocation event.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-07T21:25:40.020532+00:00","company_name":"RESMED INC","ticker":"RSMDF","filing_date":"2026-07-07"},{"id":14664,"accession_number":"0001193125-26-297658","item_number":"7.01","item_title":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"Resmed announced entry into a definitive agreement to sell its MatrixCare business to Frazier Healthcare Partners. This is a material disposition of a business segment that serves over 15,000 providers in skilled nursing, senior living, and long-term care markets. The transaction is expected to close in Q1 FY2027 and reflects a strategic portfolio shift toward high-growth sleep and connected care markets, making it a material M\u0026A event requiring 8-K disclosure under Item 1.01 or 2.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-07T21:25:40.020532+00:00","company_name":"RESMED INC","ticker":"RSMDF","filing_date":"2026-07-07"}]}